Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease

Author(s):
Zittema, D.; Versteeg, I.B.; Gansevoort, R.T.; Goor, H. van; Heer, E. de; Veraar, K.A.M.; Peters, D.J.M. (0000-0001-6974-7143); Meijer, E.
Published
2016
Publication type
Article / Letter to editor
Autosomal dominant polycystic kidney disease mouse modelAquaresisRenoprotective effectTitrated dose regimenTotal kidney volumeVasopressin V2 receptor antagonist
Date issued
2016-12-31
Language
English
Is part of
American Journal of Nephrology (2016), Vol. 44, no. 3, p. 194-203
hdl
1887/113744
doi
10.1159/000448693